Related Experiment Video
Updated: Jun 23, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Lamin A/C deficiency as a cause of familial dilated cardiomyopathy
Rohit Malhotra1, Pamela K Mason
1University of Virginia Health System, Charlottesville, Virginia 22908-0158, USA.
Insights
Lamin A/C deficiency is a significant cause of familial dilated cardiomyopathy. Patients face a poor prognosis, necessitating high clinical suspicion for diagnosis and aggressive management.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Familial dilated cardiomyopathy is often caused by Lamin A/C deficiency.
- Emerging research highlights the significance of Lamin A/C deficiency in genetic heart conditions.
Purpose of the Study:
- To review the epidemiology, diagnosis, and treatment of Lamin A/C deficiency.
- To explore disease mechanisms and current knowledge gaps.
Main Methods:
- Review of current literature on Lamin A/C deficiency.
- Analysis of screening data for dilated cardiomyopathy patients.
- Examination of findings from animal models.
Main Results:
- Lamin A/C deficiency is a key genetic cause of dilated cardiomyopathy.
- Novel mutations are frequently identified, often family-specific.
- Lamin A/C insufficiency can lead to apoptosis, particularly in the cardiac conduction system.
- The disease course is often malignant, with risks of heart failure and sudden cardiac death.
Conclusions:
- A high index of suspicion is crucial for diagnosing Lamin A/C deficiency.
- Understanding of disease mechanisms, diagnosis, and treatment remains incomplete.
- Aggressive monitoring is essential for affected individuals due to the poor prognosis.
Purpose Of Review:
Familial dilated cardiomyopathy is an underrecognized form of dilated cardiomyopathy. Lamin A/C deficiency is probably the most common cause of familial dilated cardiomyopathy. This review will focus on the emerging knowledge of epidemiology, diagnosis, and treatment of patients with lamin A/C deficiency, as well as possible disease mechanisms.
Recent Findings:
Screening of patients with dilated cardiomyopathy continues to indicate that lamin A/C deficiency is a significant cause. Multiple novel mutations have been found, suggesting that many mutations are limited to individuals or families. It is unknown how mutations cause the syndrome, although an animal model has shown that lamin A/C insufficiency causes apoptosis, particularly in the conduction system. Inheritance is predominantly autosomal dominant, but penetrance is variable. For symptomatic patients, the course is malignant, with conduction system disease, atrial fibrillation, heart failure, and sudden cardiac death. The data are contradictory, and currently, there is no clear marker for when a lamin A/C-deficient patient is at risk for sudden death.
Summary:
Lamin A/C deficiency is an important cause of dilated cardiomyopathy, and diagnosis requires that clinicians have a high index of suspicion. Our knowledge of the mechanisms, diagnosis, and treatment of lamin A/C deficiency is incomplete. It is clear that patients with this condition have a malignant course and need to be followed aggressively.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...

